0001209191-20-009272.txt : 20200213 0001209191-20-009272.hdr.sgml : 20200213 20200213164811 ACCESSION NUMBER: 0001209191-20-009272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMARD JOHN CENTRAL INDEX KEY: 0001639078 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 20611517 MAIL ADDRESS: STREET 1: 8201 E RIVERSIDE DRIVE STREET 2: BLDG 4, STE 100 CITY: AUSTIN STATE: TX ZIP: 78744 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-12 0 0001626878 XBiotech Inc. XBIT 0001639078 SIMARD JOHN 5217 WINNEBAGO LANE AUSTIN TX 78744 1 1 1 0 Chief Executive Officer Common Stock 2020-02-12 4 D 0 2016466 30.00 D 4310594 D - Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. The number of shares reported is an estimate, and will be amended when a final determination is made. /s/ Queena Han under Power of Attorney for John Simard 2020-02-13